Pfizer to Pay $430 Million Fine over Illegal Marketing
Corbis
Pfizer pleads guilty and agrees to a pay an unprecedented $430 million fine for the promotion of the drug Neurontin for uses not approved by the FDA.
Pfizer is fined $430 million for illegal marketing practices surrounding the drug Neurontin. The unprecedented fine comes after the company admitted that the epilepsy drug was promoted for several unapproved uses, including migraines, chronic pain and bipolar disease.
States had complained that the company's marketing practices inflated the costs of the Medicaid program for the poor. NPR's Snigdha Prakash reports.
Related NPR Stories
Drug Company Exec Aware of Illegal Marketing Practices Dec. 19, 2002
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.